Considerations for Critical Quality Attributes and Control Strategy for Site Specific Antibody Drug Conjugates
Time: 9:15 am
day: Day One
Details:
- Overview of the critical quality attributes (CQAs) specific to Antibody-Drug Conjugates (ADCs)
- Identification of appropriate control points for monitoring ADC CQAs
- Exploration of control strategies for ADCs, including setting appropriate control limits